| NCT ID | NCT06676956 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Pulmonary Nodules |
| Study Type | INTERVENTIONAL |
| Enrollment | 320 participants |
| Start Date | 2024-11-10 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 320 participants in total. It began in 2024-11-10 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will randomize participants undergoing a bronchoscopic biopsy of a peripheral pulmonary nodule for their standard of care to receive robotic-assisted bronchoscopy (RaB) and then staging linear endobronchial ultrasounnd (EBUS) OR staging linear EBUS first, followed by RaB. The goal of this study is to set the standard for optimizing the sequence of bronchoscopic procedures in patients at risk for early-stage malignancy.
Eligibility Criteria
Inclusion Criteria: * Peripheral Pulmonary Nodule undergoing a robotic-assisted bronchoscopy Exclusion Criteria: * lymph nodes that are enlarged or PET avid on CT prior to procedure
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06676956 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Nodules. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06676956 currently recruiting?
Yes, NCT06676956 is actively recruiting participants. Contact the research team at christopher.kapp@nm.org for enrollment information.
Where is the NCT06676956 trial being conducted?
This trial is being conducted at Sacramento, United States, Chicago, United States, Baltimore, United States, Ann Arbor, United States and 1 additional location.
Who is sponsoring the NCT06676956 clinical trial?
NCT06676956 is sponsored by Northwestern University. The trial plans to enroll 320 participants.